Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2010

Open Access 01-12-2010 | Research

Echocardiographic assessment of pulmonary vascular resistance in pulmonary arterial hypertension

Authors: Vincent Roule, Fabien Labombarda, Arnaud Pellissier, Rémi Sabatier, Thérèse Lognoné, Sophie Gomes, Emmanuel Bergot, Paul Milliez, Gilles Grollier, Eric Saloux

Published in: Cardiovascular Ultrasound | Issue 1/2010

Login to get access

Abstract

Background

Echocardiographic ratio of peak tricuspid regurgitant velocity to the right ventricular outflow tract time-velocity integral (TRV/TVI rvot) was presented as a reliable non-invasive method of estimating pulmonary vascular resistance (PVR). Studies using this technique in patients with moderate to high PVR are scarce. Left ventricular outflow tract time-velocity integral (TVI lvot) can be easier to measure than TVI rvot, especially in patients with severe pulmonary hypertension (PH) with significant anatomical modifications of the right structures.

Aims

We wanted to determine whether the TRV/TVI rvot and TRV/TVI lvot ratios would form a reliable non-invasive tool to estimate PVR in a cohort of patients with moderate to severe pulmonary vascular disease.

Methods

Doppler echocardiographic examination and right heart catheterisation were performed in 37 patients. Invasive PVR was compared with TRV/TVI rvot and TRV/TVI lvot ratios using regression analysis. Two equations were modelled and the results compared with invasive measurements using the Bland-Altman analysis. Using receiver-operating characteristics curve analysis, a cut-off value for the two ratios was generated.

Results

Correlation coefficients between invasive PVR and TRV/TVI rvot then TRV/TVI lvot were respectively 0.76 and 0.74. Two new equations were found but the Bland-Altman analysis showed wide standard deviations (respectively 3.8 and 3.9 Wood units). A TRV/TVI rvot then TRV/TVI lvot ratio cut-off value of 0.14 had a sensitivity of 93% and a specificity of 57% for the first and a sensitivity of 87% and a specificity of 57% for the second to determine PVR > 2 Wood units.

Conclusion

Echocardiography is useful for the screening of patients with pulmonary hypertension and PVR > 2 WU. It remains disappointing for accurate assessment of high PVR. TVI lvot may be an alternative to TVI rvot for patients for whom accurate TVI rvot measurement is not possible.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chemla D, Castelain V, Herve P, Lecarpentier Y, Brimioulle S: Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 2002,20(5):1314-1331. 10.1183/09031936.02.00068002CrossRefPubMed Chemla D, Castelain V, Herve P, Lecarpentier Y, Brimioulle S: Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 2002,20(5):1314-1331. 10.1183/09031936.02.00068002CrossRefPubMed
2.
go back to reference Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al.: Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). European heart journal 2009,30(20):2493-2537. 10.1093/eurheartj/ehp297CrossRefPubMed Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, et al.: Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). European heart journal 2009,30(20):2493-2537. 10.1093/eurheartj/ehp297CrossRefPubMed
3.
go back to reference Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ: A simple method for noninvasive estimation of pulmonary vascular resistance. Journal of the American College of Cardiology 2003,41(6):1021-1027. 10.1016/S0735-1097(02)02973-XCrossRefPubMed Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ: A simple method for noninvasive estimation of pulmonary vascular resistance. Journal of the American College of Cardiology 2003,41(6):1021-1027. 10.1016/S0735-1097(02)02973-XCrossRefPubMed
4.
go back to reference Rajagopalan N, Simon MA, Suffoletto MS, Shah H, Edelman K, Mathier MA, Lopez-Candales A: Noninvasive estimation of pulmonary vascular resistance in pulmonary hypertension. In Echocardiography. Volume 26Issue 5 Mount Kisco, NY; 2009:489-494. 10.1111/j.1540-8175.2008.00837.xCrossRef Rajagopalan N, Simon MA, Suffoletto MS, Shah H, Edelman K, Mathier MA, Lopez-Candales A: Noninvasive estimation of pulmonary vascular resistance in pulmonary hypertension. In Echocardiography. Volume 26Issue 5 Mount Kisco, NY; 2009:489-494. 10.1111/j.1540-8175.2008.00837.xCrossRef
5.
go back to reference Ulett KB, Marwick TH: Incorporation of pulmonary vascular resistance measurement into standard echocardiography: implications for assessment of pulmonary hypertension. In Echocardiography. Volume 24 Issue 10 Mount Kisco, NY; 2007:1020-1022. 10.1111/j.1540-8175.2007.00539.xCrossRef Ulett KB, Marwick TH: Incorporation of pulmonary vascular resistance measurement into standard echocardiography: implications for assessment of pulmonary hypertension. In Echocardiography. Volume 24 Issue 10 Mount Kisco, NY; 2007:1020-1022. 10.1111/j.1540-8175.2007.00539.xCrossRef
6.
go back to reference Vlahos AP, Feinstein JA, Schiller NB, Silverman NH: Extension of Doppler-derived echocardiographic measures of pulmonary vascular resistance to patients with moderate or severe pulmonary vascular disease. J Am Soc Echocardiogr 2008,21(6):711-714. 10.1016/j.echo.2007.10.004CrossRefPubMed Vlahos AP, Feinstein JA, Schiller NB, Silverman NH: Extension of Doppler-derived echocardiographic measures of pulmonary vascular resistance to patients with moderate or severe pulmonary vascular disease. J Am Soc Echocardiogr 2008,21(6):711-714. 10.1016/j.echo.2007.10.004CrossRefPubMed
7.
go back to reference Farzaneh-Far R, McKeown BH, Dang D, Roberts J, Schiller NB, Foster E: Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation. The American journal of cardiology 2008,101(2):259-262. 10.1016/j.amjcard.2007.07.086CrossRefPubMed Farzaneh-Far R, McKeown BH, Dang D, Roberts J, Schiller NB, Foster E: Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation. The American journal of cardiology 2008,101(2):259-262. 10.1016/j.amjcard.2007.07.086CrossRefPubMed
8.
go back to reference Ebeid MR, Ferrer PL, Robinson B, Weatherby N, Gebland H: Doppler echocardiographic evaluation of pulmonary vascular resistance in children with congenital heart disease. J Am Soc Echocardiogr 1996,9(6):822-831. 10.1016/S0894-7317(96)90474-5CrossRefPubMed Ebeid MR, Ferrer PL, Robinson B, Weatherby N, Gebland H: Doppler echocardiographic evaluation of pulmonary vascular resistance in children with congenital heart disease. J Am Soc Echocardiogr 1996,9(6):822-831. 10.1016/S0894-7317(96)90474-5CrossRefPubMed
9.
go back to reference Scapellato F, Temporelli PL, Eleuteri E, Corra U, Imparato A, Giannuzzi P: Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic failure heart failure. Journal of the American College of Cardiology 2001,37(7):1813-1819. 10.1016/S0735-1097(01)01271-2CrossRefPubMed Scapellato F, Temporelli PL, Eleuteri E, Corra U, Imparato A, Giannuzzi P: Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic failure heart failure. Journal of the American College of Cardiology 2001,37(7):1813-1819. 10.1016/S0735-1097(01)01271-2CrossRefPubMed
10.
go back to reference Haddad F, Zamanian R, Beraud AS, Schnittger I, Feinstein J, Peterson T, Yang P, Doyle R, Rosenthal D: A novel non-invasive method of estimating pulmonary vascular resistance in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr 2009,22(5):523-529. 10.1016/j.echo.2009.01.021CrossRefPubMed Haddad F, Zamanian R, Beraud AS, Schnittger I, Feinstein J, Peterson T, Yang P, Doyle R, Rosenthal D: A novel non-invasive method of estimating pulmonary vascular resistance in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr 2009,22(5):523-529. 10.1016/j.echo.2009.01.021CrossRefPubMed
11.
go back to reference Kouzu H, Nakatani S, Kyotani S, Kanzaki H, Nakanishi N, Kitakaze M: Noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. The American journal of cardiology 2009,103(6):872-876. 10.1016/j.amjcard.2008.11.039CrossRefPubMed Kouzu H, Nakatani S, Kyotani S, Kanzaki H, Nakanishi N, Kitakaze M: Noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. The American journal of cardiology 2009,103(6):872-876. 10.1016/j.amjcard.2008.11.039CrossRefPubMed
Metadata
Title
Echocardiographic assessment of pulmonary vascular resistance in pulmonary arterial hypertension
Authors
Vincent Roule
Fabien Labombarda
Arnaud Pellissier
Rémi Sabatier
Thérèse Lognoné
Sophie Gomes
Emmanuel Bergot
Paul Milliez
Gilles Grollier
Eric Saloux
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2010
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-8-21

Other articles of this Issue 1/2010

Cardiovascular Ultrasound 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine